JAPAN ANIMAL REFERRAL MEDICAL CENTER CO., LTD. Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.
Summary of Consolidated Financial Results for the Three Months Ended June 30, 2021 (Based on Japanese GAAP)
Company name: | Japan Animal Referral Medical Center (JARMeC) | |
Stock exchange listing: | Tokyo | |
Stock code: | 6039 | URL http://www.jarmec.co.jp |
Representative: | Representative Director and President | |
Inquiries: | Executive Director, Finance and | |
Administration | ||
Scheduled date to file Quarterly Securities Report: Scheduled date to commence dividend payments:
Preparation of supplementary material on quarterly financial results: Holding of quarterly financial results meeting:
August 5, 2021
TEL 044-850-1320
(Amounts less than one million yen are rounded down) | |||||||||||||
1. Consolidated financial results for the three months ended June 30, 2021 (from April 1, 2021 to June 30, 2021) | |||||||||||||
(1) Consolidated operating results (cumulative) | Percentages indicate year-on-year changes | ||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | ||||||||||
owners of parent | |||||||||||||
Millions of yen | % Millions of yen | % | Millions of yen | % Millions of yen | % | ||||||||
Three months ended June 30, 2021 | 719 | 3.0 | 88 | (13.4) | 91 | (9.6) | 62 | (9.6) | |||||
Three months ended June 30, 2020 | 699 | 4.4 | 102 | (8.6) | 100 | (11.4) | 69 | (14.2) | |||||
Earnings per share | Diluted earnings per share | ||||||||||||
Yen | Yen | ||||||||||||
Three months ended June 30, 2021 | 26.31 | 25.63 | |||||||||||
Three months ended June 30, 2020 | 29.45 | 28.49 | |||||||||||
(2) Consolidated financial position | |||||||||||||
Total assets | Net assets | Equity ratio | |||||||||||
Millions of yen | Millions of yen | % | |||||||||||
As of June 30, 2021 | 5,717 | 2,399 | 42.0 | ||||||||||
As of March 31, 2021 | 5,844 | 2,336 | 40.0 | ||||||||||
2. Cash dividends | |||||||||||||
Annual dividends per share | |||||||||||||
1st quarter-end | 2nd quarter-end | 3rd quarter-end | Fiscal year-end | Total | |||||||||
Yen | Yen | Yen | Yen | Yen | |||||||||
Year ended March 31, 2021 | - | 0.00 | - | 0.00 | 0.00 | ||||||||
Year ending March 31, 2022 | - | ||||||||||||
Year ending March 31, 2022 (Forecast) | 0.00 | - | 0.00 | 0.00 | |||||||||
3. Forecast of consolidated financial results for the year ending March 31, 2022 (from April 1, 2021 to March 31, 2022)
Percentages indicate year-on-year changes
Net sales | Operating profit | Ordinary profit | Profit attributable to | Earnings per share | |||||
owners of parent | |||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | |
Full year | 2,930 | 2.9 | 410 | 1.1 | 420 | 2.2 | 290 | 1.7 | 121.80 |
1
4. Notes
- Changes in significant subsidiaries during the three months ended June 30, 2021 (changes in specified subsidiaries resulting in the change in scope of consolidation):
- Application of special accounting methods for preparing quarterly consolidated financial statements:
No
Yes
(3) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements | |
Changes in accounting policies due to revisions to accounting standards and other regulations: | Yes |
Changes in accounting policies due to other reasons: | No |
Changes in accounting estimates: | No |
Restatement of prior period financial statements: | No |
(4) Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of June 30, 2021 | 2,436,200 | shares | As of March 31, 2021 | 2,436,200 | shares | |
Number of treasury shares at the end of the period | ||||||
As of June 30, 2021 | 55,116 | shares | As of March 31, 2021 | 55,577 | shares | |
Average number of shares during the period (cumulative from the beginning of the fiscal year) | ||||||
Three months ended June 30, 2021 | 2,380,653 | shares | Three months ended June 30, 2020 | 2,352,671 | shares |
2
Quarterly consolidated financial statements
Consolidated balance sheets
(Thousands of yen) | |||
As of March 31, 2021 | As of June 30, 2021 | ||
Assets | |||
Current assets | |||
Cash and deposits | 1,214,671 | 1,140,181 | |
Accounts receivable - trade | 148,872 | - | |
Notes and accounts receivable - trade, and contract assets | - | 144,740 | |
Merchandise | 59,709 | 60,564 | |
Supplies | 3,495 | 3,495 | |
Other | 40,631 | 40,576 | |
Allowance for doubtful accounts | (9,492) | (7,827) | |
Total current assets | 1,457,888 | 1,381,730 | |
Non-current assets | |||
Property, plant and equipment | |||
Buildings and structures, net | 1,493,714 | 1,468,697 | |
Land | 2,228,267 | 2,228,267 | |
Other, net | 476,921 | 455,837 | |
Total property, plant and equipment | 4,198,904 | 4,152,803 | |
Intangible assets | 13,965 | 12,567 | |
Investments and other assets | 173,358 | 170,124 | |
Total non-current assets | 4,386,228 | 4,335,494 | |
Total assets | 5,844,116 | 5,717,224 | |
Liabilities | |||
Current liabilities | |||
Accounts payable - trade | 48,183 | 44,688 | |
Current portion of long-term borrowings | 548,811 | 541,083 | |
Income taxes payable | 60,462 | 33,259 | |
Provision for bonuses | 67,423 | 35,275 | |
Other | 189,879 | 198,003 | |
Total current liabilities | 914,760 | 852,311 | |
Non-current liabilities | |||
Long-term borrowings | 2,525,529 | 2,398,774 | |
Retirement benefit liability | 23,650 | 23,250 | |
Asset retirement obligations | 41,279 | 41,386 | |
Other | 2,709 | 2,502 | |
Total non-current liabilities | 2,593,168 | 2,465,912 | |
Total liabilities | 3,507,928 | 3,318,224 | |
Net assets | |||
Shareholders' equity | |||
Share capital | 385,500 | 385,500 | |
Capital surplus | 332,633 | 332,075 | |
Retained earnings | 1,707,852 | 1,770,489 | |
Treasury shares | (89,798) | (89,064) | |
Total shareholders' equity | 2,336,188 | 2,399,000 | |
Total net assets | 2,336,188 | 2,399,000 | |
Total liabilities and net assets | 5,844,116 | 5,717,224 |
3
Consolidated statements of income (cumulative) and consolidated statements of comprehensive income (cumulative)
Consolidated statements of income (cumulative)
(Thousands of yen) | |||
Three months ended | Three months ended | ||
June 30, 2020 | June 30, 2021 | ||
Net sales | 699,020 | 719,787 | |
Cost of sales | 448,954 | 463,086 | |
Gross profit | 250,065 | 256,700 | |
Selling, general and administrative expenses | 147,572 | 167,894 | |
Operating profit | 102,492 | 88,805 | |
Non-operating income | |||
Rental income from buildings | 6,093 | 5,840 | |
Other | 1,126 | 764 | |
Total non-operating income | 7,220 | 6,604 | |
Non-operating expenses | |||
Interest expenses | 3,487 | 3,239 | |
Financing expenses | 984 | 987 | |
Loss on retirement of non-current assets | 3,805 | 0 | |
Other | 640 | 71 | |
Total non-operating expenses | 8,917 | 4,297 | |
Ordinary profit | 100,796 | 91,113 | |
Profit before income taxes | 100,796 | 91,113 | |
Income taxes | 31,498 | 28,476 | |
Profit | 69,297 | 62,636 | |
Profit attributable to owners of parent | 69,297 | 62,636 |
4
Consolidated statements of comprehensive income (cumulative)
(Thousands of yen) | ||
Three months ended | Three months ended | |
June 30, 2020 | June 30, 2021 | |
Profit | 69,297 | 62,636 |
Comprehensive income | 69,297 | 62,636 |
Comprehensive income attributable to | ||
Comprehensive income attributable to owners of parent | 69,297 | 62,636 |
5
Attachments
- Original document
- Permalink
Disclaimer
Japan Animal Referral Medical Center Co. Ltd. published this content on 12 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 August 2021 06:10:09 UTC.
